Catalyst Pharmaceutical Partners Announces Top-Line Results of CPP-109 Phase II(b) Trial for Cocaine Addiction

[at noodls] – CORAL GABLES, Fla., Nov. 8, 2012 (GLOBE NEWSWIRE) — Catalyst Pharmaceutical Partners, Inc. (Nasdaq:CPRX) today announced top-line results from its U.S. Phase II(b) clinical trial evaluating the use of … more

View todays social media effects on CPRX

View the latest stocks trending across Twitter. Click to view dashboard